AVTR Avantor, Inc.
NYSE · SEC CIK 1722482 · EDGAR
- Bought, last 12 months
- $8.69M 8 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 272 since 2021-07-13, latest 2026-09-23 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MEHRA SANJEEV K | Dir | $4.88M | — |
| SUMME GREGORY L | Dir | $2.06M | — |
| Ligner Emmanuel | Pres, CEO, Dir | $993.1K | — |
| LUCIER GREGORY T | Dir | $541.2K | — |
| Dingemans Simon | Dir | $203.5K | — |
| Brellier Ludovic | EVP, Bioscience, Medtech | — | — |
| Blenn Mary | EVP, COO | — | — |
| Makin Louise | Dir | — | — |
| Gourdier Benoit | EVP, Bioscience, Medtech | — | — |
| Hankamer Brittany | EVP, Chief HR Off | — | — |
Transactions 328
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-24 | 2025-02-20 | AVTR | Jones R. Brent | EVP, CFO | A - Grant | $0.00 | +80.0K | 69.6K | New | $0 |
| D | 2025-02-24 | 2025-02-20 | AVTR | Sokenu Claudius | EVP, Chief Legal, Compliance | A - Grant | $0.00 | +21.4K | 60.4K | +55% | $0 |
| D | 2025-02-24 | 2025-02-23 | AVTR | Sokenu Claudius | EVP, Chief Legal, Compliance | F - Tax | $17.30 | -2,318 | 58.1K | -4% | -$40.1K |
| 2024-11-06 | 2024-11-04 | AVTR | Makin Louise | Dir | A - Grant | $0.00 | +4,770 | 4,770 | New | $0 | |
| 2024-10-04 | 2024-10-02 | AVTR | Gourdier Benoit | EVP, Bioscience Production | F - Tax | $25.54 | -1,263 | 41.2K | -3% | -$32.3K | |
| 2024-09-06 | 2024-09-05 | AVTR | Eck Steven W | SVP, CAO | S - Sale | $25.06 | -3,525 | 29.5K | -11% | -$88.3K | |
| 2024-08-16 | 2024-08-14 | AVTR | Hankamer Brittany | EVP, Chief HR Off | F - Tax | $25.07 | -180 | 34.8K | -0.5% | -$4,513 | |
| 2024-08-01 | 2024-07-31 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $26.75 | -1,337 | 33.1K | -4% | -$35.8K | |
| M | 2024-08-01 | 2024-07-30+ | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $27.01 | -10.1K | 73.9K | -12% | -$272.8K |
| 2024-07-26 | 2024-07-24 | AVTR | Sokenu Claudius | EVP, Chief Legal, Compliance | F - Tax | $22.37 | -3,122 | 39.0K | -7% | -$69.8K | |
| 2024-07-22 | 2024-07-18 | AVTR | Sahin Kitty | EVP, Strategy, Corp Development | F - Tax | $20.74 | -3,931 | 42.3K | -9% | -$81.5K | |
| D | 2024-06-25 | 2024-06-21 | AVTR | Walker Corey | Pres Laboratory Solutions | A - Grant | $0.00 | +28.3K | 28.3K | New | $0 |
| 2024-05-13 | 2024-05-09 | AVTR | Murthy Mala | Dir | A - Grant | $0.00 | +8,477 | 27.1K | +45% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Carethers John | Dir | A - Grant | $0.00 | +8,477 | 28.8K | +42% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Peacock Jonathan M | Dir | A - Grant | $0.00 | +8,477 | 194.6K | +5% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Kang Lan | Dir | A - Grant | $0.00 | +8,477 | 30.2K | +39% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | SUMME GREGORY L | Dir | A - Grant | $0.00 | +8,477 | 41.0K | +26% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Massaro Joseph R | Dir | A - Grant | $0.00 | +8,477 | 26.9K | +46% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | Andres Juan | Dir | A - Grant | $0.00 | +8,477 | 48.4K | +21% | $0 | |
| 2024-05-13 | 2024-05-09 | AVTR | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +8,477 | 43.5K | +24% | $0 | |
| 2024-04-18 | 2024-04-16 | AVTR | Stone Randy Lee | EVP, Laboratory Solutions | F - Tax | $24.60 | -6,762 | 68.1K | -9% | -$166.3K | |
| 2024-04-08 | 2024-04-05 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $25.87 | -569 | 83.3K | -0.7% | -$14.7K | |
| 2024-03-12 | 2024-03-08 | AVTR | Eck Steven W | SVP, CAO | S - Sale | $25.63 | -3,685 | 34.4K | -10% | -$94.4K | |
| 2024-03-01 | 2024-02-29 | AVTR | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $24.52 | -4,910 | 96.2K | -5% | -$120.4K | |
| 2024-03-01 | 2024-02-29 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.53 | -13.1K | 83.9K | -13% | -$320.7K | |
| D | 2024-02-27 | 2024-02-23 | AVTR | Jones R. Brent | EVP, CFO | A - Grant | $0.00 | +25.7K | 25.7K | New | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Bramwell James | EVP Sales, Customer Excellence | A - Grant | $0.00 | +20.5K | 107.3K | +24% | $0 |
| D | 2024-02-27 | 2024-02-27 | AVTR | Bramwell James | EVP Sales, Customer Excellence | S - Sale | $24.49 | -6,203 | 101.1K | -6% | -$151.9K |
| D | 2024-02-27 | 2024-02-23 | AVTR | Sahin Kitty | EVP, Strategy, Corp Development | A - Grant | $0.00 | +12.3K | 46.2K | +36% | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Hankamer Brittany | EVP, Chief HR Off | A - Grant | $0.00 | +11.3K | 35.0K | +48% | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Gourdier Benoit | EVP, Biopharma Production | A - Grant | $0.00 | +25.7K | 42.5K | +153% | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Stone Randy Lee | EVP, Proprietary Products | A - Grant | $0.00 | +25.7K | 74.9K | +52% | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Couturier Christophe | EVP, AMEA | A - Grant | $0.00 | +9,240 | 97.0K | +11% | $0 |
| 2024-02-27 | 2024-02-23 | AVTR | Eck Steven W | SVP, CAO | A - Grant | $0.00 | +11.7K | 38.1K | +44% | $0 | |
| D | 2024-02-27 | 2024-02-23 | AVTR | Stubblefield Michael | Pres, CEO, Dir | A - Grant | $0.00 | +107.8K | 1.22M | +10% | $0 |
| D | 2024-02-27 | 2024-02-23 | AVTR | Sokenu Claudius | EVP, Chief Legal, Compliance | A - Grant | $0.00 | +17.5K | 42.1K | +71% | $0 |
| M | 2024-02-26 | 2024-02-23+ | AVTR | Hankamer Brittany | EVP, Chief HR Off | F - Tax | $24.35 | -1,227 | 24.5K | -5% | -$29.9K |
| 2024-02-26 | 2024-02-24 | AVTR | Sahin Kitty | EVP, Strategy, Corp Development | F - Tax | $24.35 | -1,059 | 33.9K | -3% | -$25.8K | |
| M | 2024-02-26 | 2024-02-22+ | AVTR | Bramwell James | EVP Sales, Customer Excellence | F - Tax | $24.47 | -5,877 | 89.3K | -6% | -$143.8K |
| 2024-02-26 | 2024-02-22 | AVTR | Bramwell James | EVP Sales, Customer Excellence | A - Grant | $0.00 | +7,432 | 92.7K | +9% | $0 | |
| M | 2024-02-26 | 2024-02-23+ | AVTR | Eck Steven W | SVP, CAO | F - Tax | $24.35 | -1,365 | 27.3K | -5% | -$33.2K |
| M | 2024-02-26 | 2024-02-22+ | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $24.50 | -4,105 | 89.3K | -4% | -$100.6K |
| 2024-02-26 | 2024-02-22 | AVTR | Couturier Christophe | EVP, AMEA | A - Grant | $0.00 | +9,290 | 91.8K | +11% | $0 | |
| M | 2024-02-26 | 2024-02-22+ | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $24.50 | -65.9K | 1.14M | -5% | -$1.61M |
| 2024-02-26 | 2024-02-22 | AVTR | Stubblefield Michael | Pres, CEO, Dir | A - Grant | $0.00 | +99.1K | 1.18M | +9% | $0 | |
| 2024-02-22 | 2024-02-20 | AVTR | Bramwell James | EVP Sales, Customer Excellence | F - Tax | $24.05 | -1,216 | 85.3K | -1% | -$29.2K | |
| 2024-02-22 | 2024-02-20 | AVTR | Hankamer Brittany | EVP, Chief HR Off | F - Tax | $24.05 | -289 | 24.9K | -1% | -$6,950 | |
| 2024-02-22 | 2024-02-20 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $24.05 | -435 | 27.8K | -2% | -$10.5K | |
| 2024-02-22 | 2024-02-20 | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $24.05 | -9,711 | 1.08M | -0.9% | -$233.5K | |
| 2024-02-22 | 2024-02-20 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $24.05 | -1,392 | 82.5K | -2% | -$33.5K | |
| 2024-01-03 | 2023-12-31 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | F - Tax | $22.83 | -4,556 | 70.7K | -6% | -$104.0K | |
| 2023-11-29 | 2023-07-18 | AVTR | Sahin Kitty | EVP, Strategy, Corp Development | F - Tax | $21.01 | -3,931 | 34.9K | -10% | -$82.6K | |
| D | 2023-10-04 | 2023-10-02 | AVTR | Gourdier Benoit | EVP, Biopharma Production | A - Grant | $0.00 | +16.8K | 16.8K | New | $0 |
| 2023-09-07 | 2023-09-07 | AVTR | Eck Steven W | SVP, CAO | S - Sale | $20.64 | -7,577 | 28.2K | -21% | -$156.4K | |
| 2023-09-05 | 2023-09-05 | AVTR | Hankamer Brittany | EVP, Chief HR Off | F - Tax | $21.70 | -309 | 25.2K | -1% | -$6,705 | |
| 2023-08-28 | 2023-08-25 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | S - Sale | $21.47 | -25.0K | 160.7K | -13% | -$536.8K | |
| 2023-08-02 | 2023-07-31 | AVTR | Eck Steven W | SVP, CAO | A - Grant | $0.00 | +14.6K | 35.8K | +69% | $0 | |
| D | 2023-07-26 | 2023-07-24 | AVTR | Sokenu Claudius | EVP, Chief Legal, Compliance | A - Grant | $0.00 | +24.6K | 24.6K | New | $0 |
| 2023-05-30 | 2023-05-26 | AVTR | Stubblefield Michael | Pres, CEO, Dir | G - Gift | $0.00 | -40.0K | 1.03M | -4% | $0 | |
| I | 2023-05-30 | 2023-05-26 | AVTR | Stubblefield Michael | Pres, CEO, Dir | G - Gift | $0.00 | +40.0K | 469.5K | +9% | $0 |
| 2023-05-19 | 2023-05-17 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $20.28 | -23.3K | 77.5K | -23% | -$471.7K | |
| 2023-05-19 | 2023-05-17 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $20.28 | -553 | 21.2K | -3% | -$11.2K | |
| 2023-05-19 | 2023-05-17 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $20.28 | -15.7K | 82.9K | -16% | -$318.5K | |
| 2023-05-19 | 2023-05-17 | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $20.28 | -106.2K | 1.17M | -8% | -$2.15M | |
| 2023-05-19 | 2023-05-17 | AVTR | Bramwell James | EVP, Strategic Partners | F - Tax | $20.28 | -18.9K | 85.4K | -18% | -$383.6K | |
| 2023-05-19 | 2023-05-17 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $20.28 | -2,210 | 185.7K | -1% | -$44.8K | |
| 2023-05-19 | 2023-05-17 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $20.28 | -19.7K | 89.0K | -18% | -$399.2K | |
| 2023-05-19 | 2023-05-17 | AVTR | Miller Justin | EVP, GC | F - Tax | $20.28 | -12.4K | 93.3K | -12% | -$252.5K | |
| 2023-05-15 | 2023-05-11 | AVTR | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +9,808 | 35.0K | +39% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | SUMME GREGORY L | Dir | A - Grant | $0.00 | +9,808 | 32.5K | +43% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Massaro Joseph R | Dir | A - Grant | $0.00 | +9,808 | 18.5K | +113% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Shaw Christi | Dir | A - Grant | $0.00 | +9,808 | 36.3K | +37% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Peacock Jonathan M | Dir | A - Grant | $0.00 | +9,808 | 186.1K | +6% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Murthy Mala | Dir | A - Grant | $0.00 | +9,808 | 18.6K | +111% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Carethers John | Dir | A - Grant | $0.00 | +9,808 | 20.3K | +94% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Andres Juan | Dir | A - Grant | $0.00 | +9,808 | 39.9K | +33% | $0 | |
| 2023-05-15 | 2023-05-11 | AVTR | Kang Lan | Dir | A - Grant | $0.00 | +9,808 | 21.7K | +82% | $0 | |
| D | 2023-04-18 | 2023-04-16 | AVTR | Stone Randy Lee | EVP, Proprietary Products | A - Grant | $0.00 | +48.3K | 48.3K | New | $0 |
| 2023-04-13 | 2023-04-11 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $21.18 | -1,498 | 98.7K | -1% | -$31.7K | |
| 2023-04-06 | 2023-04-05 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $20.82 | -569 | 100.1K | -0.6% | -$11.8K | |
| 2023-03-06 | 2023-03-03 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,914 | 108.7K | -3% | -$97.8K | |
| 2023-03-01 | 2023-02-27 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.00 | -3,059 | 112.6K | -3% | -$76.5K | |
| 2023-03-01 | 2023-02-28 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.32 | -2,324 | 100.7K | -2% | -$56.5K | |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $24.60 | -4,122 | 104.9K | -4% | -$101.4K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Szlosek Thomas A | EVP, CFO | A - Grant | $0.00 | +22.3K | 106.9K | +26% | $0 |
| D | 2023-02-27 | 2023-02-24 | AVTR | Eck Steven W | SVP, CAO | A - Grant | $0.00 | +5,347 | 22.2K | +32% | $0 |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Eck Steven W | SVP, CAO | F - Tax | $24.61 | -926 | 21.7K | -4% | -$22.8K |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $24.61 | -3,933 | 115.7K | -3% | -$96.8K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Brophy Gerard | EVP, Biopharma Production | A - Grant | $0.00 | +20.3K | 117.7K | +21% | $0 |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | F - Tax | $24.61 | -2,310 | 64.4K | -3% | -$56.8K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | A - Grant | $0.00 | +12.2K | 76.6K | +19% | $0 |
| D | 2023-02-27 | 2023-02-24 | AVTR | Sahin Kitty | EVP, Strategy, Corp Development | A - Grant | $0.00 | +12.2K | 38.9K | +46% | $0 |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $24.61 | -15.1K | 1.19M | -1% | -$371.7K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Stubblefield Michael | Pres, CEO, Dir | A - Grant | $0.00 | +99.0K | 1.29M | +8% | $0 |
| D | 2023-02-27 | 2023-02-23 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.24 | -3,078 | 94.4K | -3% | -$74.6K |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $24.61 | -883 | 97.4K | -0.9% | -$21.7K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Couturier Christophe | EVP, AMEA | A - Grant | $0.00 | +9,138 | 103.5K | +10% | $0 |
| D | 2023-02-27 | 2023-02-24 | AVTR | Miller Justin | EVP, GC | A - Grant | $0.00 | +9,138 | 106.3K | +9% | $0 |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Miller Justin | EVP, GC | F - Tax | $24.61 | -1,028 | 105.8K | -1.0% | -$25.3K |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $24.61 | -512 | 187.9K | -0.3% | -$12.6K |
Purchase Sale Sale after option exercise All abbreviations